Breast Cancer Clinical Trial

Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

Summary

The goal of this study is to study NIS expression in benign and malignant breast and thyroid samples using archival formalin-fixed paraffin-embedded tissue sections.

View Full Description

Full Description

The objective of the study is to further understanding of proteins that occur in both normal cells and tumor cells and to learn more about certain diseases and potential alternative treatments for these diseases.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient must be over the age of 18.
Patients must have benign and malignant breast and thyroid cancer.
Patient mus sign consent form.

Exclusion Criteria:

1. No children will be allowed.

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT00568438

Recruitment Status:

Recruiting

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University School of Medicine
Stanford California, 94305, United States More Info
Donna Adelman
Contact
650-724-1953
[email protected]
Cancer Clinical Trials Office
Contact
(650) 498-7061
Irene L Wapnir, MD
Principal Investigator
Ralph S. Greco MD
Sub-Investigator
Kent W Nowels
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

300

Study ID:

NCT00568438

Recruitment Status:

Recruiting

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider